Clinical Trial Update: The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 study evaluating the safety and efficacy of Immuncell-LC for refractory metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Immuncell-LC

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN